Updates in KRAS G12C Mutant NSCLC: Demographics, Clinical Features, Genomics, and Treatment
By
Dana-Farber Cancer Institute
FEATURING
Biagio Ricciuti
By
Dana-Farber Cancer Institute
FEATURING
Biagio Ricciuti
Login to view comments.
Click here to Login